Norris Medicines Ltd
06 Nov 2026 12:00 AM
Norris Medicines to review financial results at November board meeting in Ankleshwar,
Norris Medicines Limited will hold a board meeting on November 14, 2026, at its registered office in Ankleshwar, Gujarat, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026, along with the limited review report thereof, according to a regulatory filing with the BSE Limited. The company’s trading window for securities has been closed since October 1, 2026, and will remain so until 48 hours after the unaudited financial results are announced on the stock exchange.
Norris Medicines Ltd
03 Sep 2026 12:00 AM
Norris Medicines’ board approved the Directors Report and scheduled the Annual General Meeting,
Norris Medicines Limited informed the BSE that its board of directors approved the company’s Directors Report for the financial year ended March 31, 2026, and convened the 35th Annual General Meeting on September 29, 2026, via video conferencing or other audio-visual means, with Mr. Hemant Shetye, or Mr. Kunal Sakpal, appointed as scrutinizer and Purva Sharegistry (India) Pvt. Ltd. authorized to facilitate the e-voting process.
Norris Medicines Ltd
10 Aug 2026 12:00 AM
Norris Medicines to convene board meeting,
Norris Medicines will hold a meeting of the Board of Directors of the Company on 14 August 2026.
Norris Medicines Ltd
01 Jun 2026 12:00 AM
Norris Medicines reports standalone net profit of Rs 0.05 crore in the March 2026 quarter,
Net profit of Norris Medicines reported to Rs 0.05 crore in the quarter ended March 2026 as against net loss of Rs 0.23 crore during the previous quarter ended March 2025. Sales declined 48.16% to Rs 1.41 crore in the quarter ended March 2026 as against Rs 2.72 crore during the previous quarter ended March 2025.For the full year,net loss reported to Rs 0.28 crore in the year ended March 2026 as against net loss of Rs 1.24 crore during the previous year ended March 2025. Sales rose 39.69% to Rs 8.13 crore in the year ended March 2026 as against Rs 5.82 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales1.412.72 -48 8.135.82 40 OPM %21.282.57 -8.12-4.47 - PBDT0.17-0.03 LP 0.21-0.64 LP PBT0.05-0.17 LP -0.28-1.18 76 NP0.05-0.23 LP -0.28-1.24 77 Powered by Capital Market - Live News
Norris Medicines Ltd
26 May 2026 12:00 AM
Norris Medicines to discuss results,
Norris Medicines will hold a meeting of the Board of Directors of the Company on 30 May 2026.
Subscribe for our
newsletter
newsletter
HSL Mobile App